Keynote Presentation: Microfluidics and CRISPR-Diagnostics/Therapy with Live Q&A

Presented By: Xingyu Jiang, PhD

Speaker Biography: Xingyu Jiang obtained his bachelor's degree in chemistry from the University of Chicago in 1999 and his Ph.D. from Harvard University in 2004. In 2005, he began independent work at the National Center for Nanoscience and Technology (an affiliate of the Chinese Academy of Sciences). In 2018 he was appointed a Chair Professor at the Southern University of Science and Technology. Xingyu was awarded many grants including the National Distinguished Youth Science Fund and National Key Research Project by the Ministry of Science and Technology. He is a fellow of the Royal Society of Chemistry (UK) and American Institude of Medical and Biological Engneering. He is on the editorial board of Lab on a Chip. He has published more than 400 papers in peer-reviewed journals. His research interests include microfluidic chips and nanobiomedicine.

Webinar: Keynote Presentation: Microfluidics and CRISPR-Diagnostics/Therapy with Live Q&A

Webinar Abstract: Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate sample pretreatment and nucleic acid detection in a rapid, cost-effective, and non-labor-intensive manner. The most widely used polymerase chain reaction (PCR)-based nucleic acid assays suffer from complexity, high personnel and laboratory requirements, and contamination. Highly miniaturized microfluidic chips provide the necessary tools to integrate complex nucleic acid detection processes. Various microfluidic chips coupled with clustered regularly interspaced short palindromic repeat (CRISPR) have been developed for the rapid detection of nucleic acids. These tools offer a range of advantages including high sensitivity, high automation, high specificity, and a high level of integration performance, and we have developed a series of nucleic acid detection systems based on CRISPR and microfluidic technologies...

Labroots on Social:
Facebook:   / labrootsinc  
Twitter:   / labroots  
LinkedIn:   / labroots  
Instagram:   / labrootsinc  
Pinterest:   / labroots  
SnapChat: labroots_inc